Pasithea Therapeutics (KTTA) Q2 2026 Earnings

May 15Confirmed
Q2 2025
Q2 2025
Q4 2025
Q2 2026
-0.66
-0.48
-0.3
-0.12

Details

Expected EPS
-0.12
Actual EPS
-0.12
Surprise EPS
0
Surprise Percent
+0%

Description

⁨Pasithea Therapeutics⁩ (⁦KTTA⁩) has reported earnings of ⁦-0.12⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts